Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: A novel anti-tumor agent

Daniel A. Saltzman, Emmanuel Katsanis, Charles P. Heise, Diane E. Hasz, Sandra M. Kelly, Roy Curtiss, Arnold S. Leonard, Peter M. Anderson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Currently, there is no effective treatment for unresectable hepatic malignancies. Salmonella sp. are known to naturally track to the liver during active infection. A live biological vector was developed for delivery of Interleukin-2 (IL-2) to the liver for anti-tumor purposes. The avirulent and highly immunogenic c4550 strain of Salmonella typhimurium was used to express the IL-2 protein [renamed c4550(pIL-2)]. We have previously demonstrated that the c4550(pIL-2) produces biologically active IL-2 (up to 46.2 IU/ml) and that a single gavage feeding of 107 colony forming units (cfu) of c4550(pIL- 2) significantly reduced the number of hepatic metastases when compared to animals fed salmonella lacking the IL-2 gene or non-treated controls. The goal of the current studies was to determine the pattern of splenic and hepatic colonization of Salmonella-IL2. Hepatic and splenic colonization was determined following administration of 107 cfu of c4550(pIL-2) and c4550(pYA292) via a single garage feeding to C57BL/6 mice. Five experiments of antibiotic regimen administration were conducted where splenic and hepatic homogenates were cultured after 14 days of parenteral and/or oral antibiotics. The natural history of hepatic and splenic colonization was also determined for animals without antibiotic treatment. Despite administration of various antibiotic regimens using different routes, eradication of salmonella with and without IL-2 was not achieved. Salmonella, however, was not cultured from hepatic and splenic tissue at 4 months after a single gavage feeding of salmonella with no specific treatment. In conclusion, oral administration of c4550(pIL-2) may represent a novel form of in vivo biotherapy for unresectable hepatic malignancies. Antibiotics do not accelerate eradication of this bacteria and it appears that c4550(pIL-2) follows the natural pathophysiological of salmonella infection in which eradication from the splenic and hepatic tissue occurs over a period of 2-4 months.

Original languageEnglish (US)
Pages (from-to)37-45
Number of pages9
JournalCancer Biotherapy and Radiopharmaceuticals
Volume12
Issue number1
StatePublished - Feb 1997
Externally publishedYes

Fingerprint

Salmonella typhimurium
Interleukin-2
Liver
Salmonella
Genes
Neoplasms
Anti-Bacterial Agents
Stem Cells
Biological Therapy
Salmonella Infections
Natural History
Inbred C57BL Mouse
Oral Administration
Neoplasm Metastasis
Bacteria

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2 : A novel anti-tumor agent. / Saltzman, Daniel A.; Katsanis, Emmanuel; Heise, Charles P.; Hasz, Diane E.; Kelly, Sandra M.; Curtiss, Roy; Leonard, Arnold S.; Anderson, Peter M.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 12, No. 1, 02.1997, p. 37-45.

Research output: Contribution to journalArticle

Saltzman, Daniel A. ; Katsanis, Emmanuel ; Heise, Charles P. ; Hasz, Diane E. ; Kelly, Sandra M. ; Curtiss, Roy ; Leonard, Arnold S. ; Anderson, Peter M. / Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2 : A novel anti-tumor agent. In: Cancer Biotherapy and Radiopharmaceuticals. 1997 ; Vol. 12, No. 1. pp. 37-45.
@article{5a70d993364d42ada20aebb8c65c8179,
title = "Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: A novel anti-tumor agent",
abstract = "Currently, there is no effective treatment for unresectable hepatic malignancies. Salmonella sp. are known to naturally track to the liver during active infection. A live biological vector was developed for delivery of Interleukin-2 (IL-2) to the liver for anti-tumor purposes. The avirulent and highly immunogenic c4550 strain of Salmonella typhimurium was used to express the IL-2 protein [renamed c4550(pIL-2)]. We have previously demonstrated that the c4550(pIL-2) produces biologically active IL-2 (up to 46.2 IU/ml) and that a single gavage feeding of 107 colony forming units (cfu) of c4550(pIL- 2) significantly reduced the number of hepatic metastases when compared to animals fed salmonella lacking the IL-2 gene or non-treated controls. The goal of the current studies was to determine the pattern of splenic and hepatic colonization of Salmonella-IL2. Hepatic and splenic colonization was determined following administration of 107 cfu of c4550(pIL-2) and c4550(pYA292) via a single garage feeding to C57BL/6 mice. Five experiments of antibiotic regimen administration were conducted where splenic and hepatic homogenates were cultured after 14 days of parenteral and/or oral antibiotics. The natural history of hepatic and splenic colonization was also determined for animals without antibiotic treatment. Despite administration of various antibiotic regimens using different routes, eradication of salmonella with and without IL-2 was not achieved. Salmonella, however, was not cultured from hepatic and splenic tissue at 4 months after a single gavage feeding of salmonella with no specific treatment. In conclusion, oral administration of c4550(pIL-2) may represent a novel form of in vivo biotherapy for unresectable hepatic malignancies. Antibiotics do not accelerate eradication of this bacteria and it appears that c4550(pIL-2) follows the natural pathophysiological of salmonella infection in which eradication from the splenic and hepatic tissue occurs over a period of 2-4 months.",
author = "Saltzman, {Daniel A.} and Emmanuel Katsanis and Heise, {Charles P.} and Hasz, {Diane E.} and Kelly, {Sandra M.} and Roy Curtiss and Leonard, {Arnold S.} and Anderson, {Peter M.}",
year = "1997",
month = "2",
language = "English (US)",
volume = "12",
pages = "37--45",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2

T2 - A novel anti-tumor agent

AU - Saltzman, Daniel A.

AU - Katsanis, Emmanuel

AU - Heise, Charles P.

AU - Hasz, Diane E.

AU - Kelly, Sandra M.

AU - Curtiss, Roy

AU - Leonard, Arnold S.

AU - Anderson, Peter M.

PY - 1997/2

Y1 - 1997/2

N2 - Currently, there is no effective treatment for unresectable hepatic malignancies. Salmonella sp. are known to naturally track to the liver during active infection. A live biological vector was developed for delivery of Interleukin-2 (IL-2) to the liver for anti-tumor purposes. The avirulent and highly immunogenic c4550 strain of Salmonella typhimurium was used to express the IL-2 protein [renamed c4550(pIL-2)]. We have previously demonstrated that the c4550(pIL-2) produces biologically active IL-2 (up to 46.2 IU/ml) and that a single gavage feeding of 107 colony forming units (cfu) of c4550(pIL- 2) significantly reduced the number of hepatic metastases when compared to animals fed salmonella lacking the IL-2 gene or non-treated controls. The goal of the current studies was to determine the pattern of splenic and hepatic colonization of Salmonella-IL2. Hepatic and splenic colonization was determined following administration of 107 cfu of c4550(pIL-2) and c4550(pYA292) via a single garage feeding to C57BL/6 mice. Five experiments of antibiotic regimen administration were conducted where splenic and hepatic homogenates were cultured after 14 days of parenteral and/or oral antibiotics. The natural history of hepatic and splenic colonization was also determined for animals without antibiotic treatment. Despite administration of various antibiotic regimens using different routes, eradication of salmonella with and without IL-2 was not achieved. Salmonella, however, was not cultured from hepatic and splenic tissue at 4 months after a single gavage feeding of salmonella with no specific treatment. In conclusion, oral administration of c4550(pIL-2) may represent a novel form of in vivo biotherapy for unresectable hepatic malignancies. Antibiotics do not accelerate eradication of this bacteria and it appears that c4550(pIL-2) follows the natural pathophysiological of salmonella infection in which eradication from the splenic and hepatic tissue occurs over a period of 2-4 months.

AB - Currently, there is no effective treatment for unresectable hepatic malignancies. Salmonella sp. are known to naturally track to the liver during active infection. A live biological vector was developed for delivery of Interleukin-2 (IL-2) to the liver for anti-tumor purposes. The avirulent and highly immunogenic c4550 strain of Salmonella typhimurium was used to express the IL-2 protein [renamed c4550(pIL-2)]. We have previously demonstrated that the c4550(pIL-2) produces biologically active IL-2 (up to 46.2 IU/ml) and that a single gavage feeding of 107 colony forming units (cfu) of c4550(pIL- 2) significantly reduced the number of hepatic metastases when compared to animals fed salmonella lacking the IL-2 gene or non-treated controls. The goal of the current studies was to determine the pattern of splenic and hepatic colonization of Salmonella-IL2. Hepatic and splenic colonization was determined following administration of 107 cfu of c4550(pIL-2) and c4550(pYA292) via a single garage feeding to C57BL/6 mice. Five experiments of antibiotic regimen administration were conducted where splenic and hepatic homogenates were cultured after 14 days of parenteral and/or oral antibiotics. The natural history of hepatic and splenic colonization was also determined for animals without antibiotic treatment. Despite administration of various antibiotic regimens using different routes, eradication of salmonella with and without IL-2 was not achieved. Salmonella, however, was not cultured from hepatic and splenic tissue at 4 months after a single gavage feeding of salmonella with no specific treatment. In conclusion, oral administration of c4550(pIL-2) may represent a novel form of in vivo biotherapy for unresectable hepatic malignancies. Antibiotics do not accelerate eradication of this bacteria and it appears that c4550(pIL-2) follows the natural pathophysiological of salmonella infection in which eradication from the splenic and hepatic tissue occurs over a period of 2-4 months.

UR - http://www.scopus.com/inward/record.url?scp=0030947948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030947948&partnerID=8YFLogxK

M3 - Article

C2 - 10851445

AN - SCOPUS:0030947948

VL - 12

SP - 37

EP - 45

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 1

ER -